Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

Pro Medicus Secures A$80M Amid 60% Selloff Pro Medicus (ASX:PME) jumped 4.3% on Monday after securing a A$37 million contract renewal with Northwestern Medicine at higher per-exam fees than its…

ByUjjwal Maheshwari

09

Apr 2026

Healthcare Stocks

Pro Medicus (ASX:PME) Rallies on $23m Maryland Contract. Is This the Dip Investors Should Be Buying?

Pro Medicus jumps on new US contract Pro Medicus (ASX:PME) jumped more than 8% on Wednesday after sealing a five-year, A$23 million contract with the University of Maryland Medical System.…

ByUjjwal Maheshwari

08

Apr 2026

Healthcare Stocks

Mesoblast (ASX:MSB) Falls 7% Despite Record US$30.3M Ryoncil Quarter- Is This the Dip to Buy?

Mesoblast Shares Fall Despite Record Sales Mesoblast (ASX: MSB) shares fell around 7% on Tuesday, trading near A$1.98, after the company reported its best-ever quarterly Ryoncil sales. Net sales for…

ByUjjwal Maheshwari

07

Apr 2026

Healthcare Stocks

These 2 ASX Healthcare Stocks Are Quietly Cashing In on the AI Revolution

ASX Healthcare Stocks Benefiting From AI Artificial intelligence is reshaping healthcare faster than most investors realise. Hospital imaging systems, pathology labs, and diagnostic platforms are all being transformed by AI…

ByUjjwal Maheshwari

30

Mar 2026

Healthcare Stocks

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

4 ASX Healthcare Stocks to Buy at Valuation Lows ASX healthcare stocks have had a brutal run. Five years of underperformance, persistent earnings downgrades, and aggressive rate hikes have pushed…

ByUjjwal Maheshwari

25

Mar 2026

Healthcare Stocks

Is Echo IQ (ASX:EIQ) a Buy? Mayo Clinic Deal and ASX Index Entry Signal a Major Turning Point

Echo IQ Gains on Mayo Deal and FDA Filing Echo IQ (ASX: EIQ) surged 17% on Tuesday on the back of two catalysts arriving at once. The company has joined…

ByUjjwal Maheshwari

17

Mar 2026

Healthcare Stocks

Tetratherix (ASX: TTX) Surges 22% After Signing US$30 Million GLP-1 Deal: Is TTX a Buy Right Now?

Tetratherix jumps on new US GLP-1 deal Tetratherix (ASX: TTX) surged 22% on Monday after signing an exclusive deal with US consumer health company Superpower Health to develop a new…

ByUjjwal Maheshwari

11

Mar 2026

Healthcare Stocks

Orthocell (ASX: OCC) Lines Up UK Distributor for Remplir Ahead of Approval- Is Now the Time to Buy?

Orthocell Moves Closer to UK Growth Orthocell (ASX: OCC) just made a move that not every small-cap medtech company would make. Rather than waiting for regulatory approval before signing a…

ByUjjwal Maheshwari

10

Mar 2026

Healthcare Stocks

Pro Medicus (ASX: PME) Falls Despite A$40m in US Renewals: Is This a Buying Opportunity?

Pro Medicus Dips Despite Strong Renewals Pro Medicus (ASX: PME) slipped around 1% on Monday despite announcing approximately A$40m in US contract renewals, including an expanded deal with MedStar Health…

ByUjjwal Maheshwari

24

Feb 2026

Healthcare Stocks

Is Fisher & Paykel Healthcare (ASX:FPH) a Buy After Upgrading Guidance? The Tariff Risk Investors Are Ignoring

Fisher & Paykel Healthcare (ASX: FPH) lifted its FY26 guidance on Monday, now expecting around NZ$2.30 billion in revenue and NZ$450 million to NZ$470 million in net profit. Both figures…

ByUjjwal Maheshwari

Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

Pro Medicus (ASX:PME) Rallies on $23m Maryland Contract. Is This the Dip Investors Should Be Buying?

Mesoblast (ASX:MSB) Falls 7% Despite Record US$30.3M Ryoncil Quarter- Is This the Dip to Buy?

These 2 ASX Healthcare Stocks Are Quietly Cashing In on the AI Revolution

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

Is Echo IQ (ASX:EIQ) a Buy? Mayo Clinic Deal and ASX Index Entry Signal a Major Turning Point

Tetratherix (ASX: TTX) Surges 22% After Signing US$30 Million GLP-1 Deal: Is TTX a Buy Right Now?

Orthocell (ASX: OCC) Lines Up UK Distributor for Remplir Ahead of Approval- Is Now the Time to Buy?

Pro Medicus (ASX: PME) Falls Despite A$40m in US Renewals: Is This a Buying Opportunity?

Is Fisher & Paykel Healthcare (ASX:FPH) a Buy After Upgrading Guidance? The Tariff Risk Investors Are Ignoring

PLS Group (ASX:PLS) Hits Record High on...

Narryer Metals (ASX:NYM) Tim Goyder Back...

Sovereign Metals (ASX:SVM) DFS lands,$2....

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here